Correlation Between Basilea Pharmaceutica and Idorsia

Can any of the company-specific risk be diversified away by investing in both Basilea Pharmaceutica and Idorsia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Basilea Pharmaceutica and Idorsia into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Basilea Pharmaceutica AG and Idorsia, you can compare the effects of market volatilities on Basilea Pharmaceutica and Idorsia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Basilea Pharmaceutica with a short position of Idorsia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Basilea Pharmaceutica and Idorsia.

Diversification Opportunities for Basilea Pharmaceutica and Idorsia

0.71

Correlation Coefficient

Basilea Pharmaceutica  Idorsia

Poor diversification

The 3 months correlation between Basilea and Idorsia is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Basilea Pharmaceutica AG and Idorsia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Idorsia and Basilea Pharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Basilea Pharmaceutica AG are associated (or correlated) with Idorsia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Idorsia has no effect on the direction of Basilea Pharmaceutica i.e., Basilea Pharmaceutica and Idorsia go up and down completely randomly.

Pair Corralation between Basilea Pharmaceutica and Idorsia

Assuming the 90 days trading horizon Basilea Pharmaceutica AG is expected to generate 0.13 times more return on investment than Idorsia. However, Basilea Pharmaceutica AG is 7.81 times less risky than Idorsia. It trades about -0.15 of its potential returns per unit of risk. Idorsia is currently generating about -0.07 per unit of risk. If you would invest  4,650  in Basilea Pharmaceutica AG on September 27, 2024 and sell it today you would lose (535.00) from holding Basilea Pharmaceutica AG or give up 11.51% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Basilea Pharmaceutica AG  vs.  Idorsia

Basilea Pharmaceutica

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Basilea Pharmaceutica AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Idorsia

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Idorsia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Basilea Pharmaceutica and Idorsia

The main advantage of trading using opposite Basilea Pharmaceutica and Idorsia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Basilea Pharmaceutica position performs unexpectedly, Idorsia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Idorsia will offset losses from the drop in Idorsia's long position.

The idea behind Basilea Pharmaceutica AG and Idorsia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.